FMP

FMP

Enter

LXRX - Lexicon Pharmaceutic...

photo-url-https://images.financialmodelingprep.com/symbol/LXRX.png

Lexicon Pharmaceuticals, Inc.

LXRX

NASDAQ

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

0.496 USD

-0.0076 (-1.53%)

LXRX Ratings

Overall Rating

1

Discounted Cash Flow

1

Return on Equity

1

Return on Assets

1

Debt to Equity

1

Price to Earnings

1

Price to Book

3

Upgrades & Downgrades

Rating Distribution

Buy1

Hold0

Sell0

TheFly

a month ago
Mar 7, 2025

Overweight

Overweight

Price Targets

We are unable to load the data!

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep